Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

HIPO vs LMND

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
HIPO
Hippo Holdings Inc.

Insurance - Specialty

Financial ServicesNYSE • US
Market Cap$713M
5Y Perf.-90.4%
LMND
Lemonade, Inc.

Insurance - Property & Casualty

Financial ServicesNYSE • US
Market Cap$4.07B
5Y Perf.-63.5%

HIPO vs LMND — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
HIPO logoHIPO
LMND logoLMND
IndustryInsurance - SpecialtyInsurance - Property & Casualty
Market Cap$713M$4.07B
Revenue (TTM)$480M$821M
Net Income (TTM)$113M$-139M
Gross Margin40.5%47.6%
Operating Margin24.2%-16.3%
Forward P/E114.1x
Total Debt$52M$182M
Cash & Equiv.$250M$385M

HIPO vs LMNDLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

HIPO
LMND
StockJan 21May 26Return
Hippo Holdings Inc. (HIPO)1009.6-90.4%
Lemonade, Inc. (LMND)10036.5-63.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: HIPO vs LMND

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HIPO leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Lemonade, Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
HIPO
Hippo Holdings Inc.
The Insurance Pick

HIPO carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • beta 1.40
  • Rev growth 25.9%, EPS growth 235.4%, 3Y rev CAGR 57.6%
  • Lower volatility, beta 1.40, Low D/E 12.0%, current ratio 0.35x
Best for: income & stability and growth exposure
LMND
Lemonade, Inc.
The Insurance Pick

LMND is the clearest fit if your priority is long-term compounding.

  • -23.6% 10Y total return vs HIPO's -90.5%
  • 40.2% revenue growth vs HIPO's 25.9%
  • +74.9% vs HIPO's +14.0%
Best for: long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthLMND logoLMND40.2% revenue growth vs HIPO's 25.9%
ValueHIPO logoHIPOBetter valuation composite
Quality / MarginsHIPO logoHIPOCombined ratio 0.9 vs LMND's 1.2 (lower = better underwriting)
Stability / SafetyHIPO logoHIPOBeta 1.40 vs LMND's 2.75, lower leverage
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)LMND logoLMND+74.9% vs HIPO's +14.0%
Efficiency (ROA)HIPO logoHIPO6.0% ROA vs LMND's -7.4%, ROIC 22.8% vs -36.8%

HIPO vs LMND — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

HIPOHippo Holdings Inc.
FY 2024
Services Segment
100.0%$48M
LMNDLemonade, Inc.
FY 2025
Reportable Segment
100.0%$738M

HIPO vs LMND — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLHIPOLAGGINGLMND

Income & Cash Flow (Last 12 Months)

HIPO leads this category, winning 4 of 6 comparable metrics.

LMND is the larger business by revenue, generating $821M annually — 1.7x HIPO's $480M. HIPO is the more profitable business, keeping 23.4% of every revenue dollar as net income compared to LMND's -16.9%. On growth, LMND holds the edge at +55.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricHIPO logoHIPOHippo Holdings In…LMND logoLMNDLemonade, Inc.
RevenueTrailing 12 months$480M$821M
EBITDAEarnings before interest/tax$116M-$121M
Net IncomeAfter-tax profit$113M-$139M
Free Cash FlowCash after capex$50M$20M
Gross MarginGross profit ÷ Revenue+40.5%+47.6%
Operating MarginEBIT ÷ Revenue+24.2%-16.3%
Net MarginNet income ÷ Revenue+23.4%-16.9%
FCF MarginFCF ÷ Revenue+10.4%+2.4%
Rev. Growth (YoY)Latest quarter vs prior year+10.2%+55.0%
EPS Growth (YoY)Latest quarter vs prior year+114.1%+45.3%
HIPO leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

HIPO leads this category, winning 2 of 3 comparable metrics.
MetricHIPO logoHIPOHippo Holdings In…LMND logoLMNDLemonade, Inc.
Market CapShares × price$713M$4.1B
Enterprise ValueMkt cap + debt − cash$515M$3.9B
Trailing P/EPrice ÷ TTM EPS12.34x-23.04x
Forward P/EPrice ÷ next-FY EPS est.114.13x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple8.14x
Price / SalesMarket cap ÷ Revenue1.52x5.52x
Price / BookPrice ÷ Book value/share1.63x7.13x
Price / FCFMarket cap ÷ FCF78.35x
HIPO leads this category, winning 2 of 3 comparable metrics.

Profitability & Efficiency

HIPO leads this category, winning 7 of 8 comparable metrics.

HIPO delivers a 27.4% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $-27 for LMND. HIPO carries lower financial leverage with a 0.12x debt-to-equity ratio, signaling a more conservative balance sheet compared to LMND's 0.34x. On the Piotroski fundamental quality scale (0–9), HIPO scores 5/9 vs LMND's 4/9, reflecting solid financial health.

MetricHIPO logoHIPOHippo Holdings In…LMND logoLMNDLemonade, Inc.
ROE (TTM)Return on equity+27.4%-26.5%
ROA (TTM)Return on assets+6.0%-7.4%
ROICReturn on invested capital+22.8%-36.8%
ROCEReturn on capital employed+6.9%-22.7%
Piotroski ScoreFundamental quality 0–954
Debt / EquityFinancial leverage0.12x0.34x
Net DebtTotal debt minus cash-$198M-$203M
Cash & Equiv.Liquid assets$250M$385M
Total DebtShort + long-term debt$52M$182M
Interest CoverageEBIT ÷ Interest expense
HIPO leads this category, winning 7 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

LMND leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in LMND five years ago would be worth $6,962 today (with dividends reinvested), compared to $1,107 for HIPO. Over the past 12 months, LMND leads with a +74.9% total return vs HIPO's +14.0%. The 3-year compound annual growth rate (CAGR) favors LMND at 48.3% vs HIPO's 14.0% — a key indicator of consistent wealth creation.

MetricHIPO logoHIPOHippo Holdings In…LMND logoLMNDLemonade, Inc.
YTD ReturnYear-to-date-8.6%-30.2%
1-Year ReturnPast 12 months+14.0%+74.9%
3-Year ReturnCumulative with dividends+48.1%+226.0%
5-Year ReturnCumulative with dividends-88.9%-30.4%
10-Year ReturnCumulative with dividends-90.5%-23.6%
CAGR (3Y)Annualised 3-year return+14.0%+48.3%
LMND leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

HIPO leads this category, winning 2 of 2 comparable metrics.

HIPO is the less volatile stock with a 1.40 beta — it tends to amplify market swings less than LMND's 2.75 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HIPO currently trades 70.3% from its 52-week high vs LMND's 53.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricHIPO logoHIPOHippo Holdings In…LMND logoLMNDLemonade, Inc.
Beta (5Y)Sensitivity to S&P 5001.40x2.75x
52-Week HighHighest price in past year$38.98$99.90
52-Week LowLowest price in past year$19.92$28.71
% of 52W HighCurrent price vs 52-week peak+70.3%+53.1%
RSI (14)Momentum oscillator 0–10055.241.9
Avg Volume (50D)Average daily shares traded113K1.9M
HIPO leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates HIPO as "Buy" and LMND as "Buy". Consensus price targets imply 37.1% upside for LMND (target: $73) vs 3.6% for HIPO (target: $28).

MetricHIPO logoHIPOHippo Holdings In…LMND logoLMNDLemonade, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$28.38$72.67
# AnalystsCovering analysts615
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+2.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

HIPO leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). LMND leads in 1 (Total Returns).

Best OverallHippo Holdings Inc. (HIPO)Leads 4 of 6 categories
Loading custom metrics...

HIPO vs LMND: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is HIPO or LMND a better buy right now?

For growth investors, Lemonade, Inc.

(LMND) is the stronger pick with 40. 2% revenue growth year-over-year, versus 25. 9% for Hippo Holdings Inc. (HIPO). Hippo Holdings Inc. (HIPO) offers the better valuation at 12. 3x trailing P/E (114. 1x forward), making it the more compelling value choice. Analysts rate Hippo Holdings Inc. (HIPO) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — HIPO or LMND?

Over the past 5 years, Lemonade, Inc.

(LMND) delivered a total return of -30. 4%, compared to -88. 9% for Hippo Holdings Inc. (HIPO). Over 10 years, the gap is even starker: LMND returned -23. 6% versus HIPO's -90. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — HIPO or LMND?

By beta (market sensitivity over 5 years), Hippo Holdings Inc.

(HIPO) is the lower-risk stock at 1. 40β versus Lemonade, Inc. 's 2. 75β — meaning LMND is approximately 97% more volatile than HIPO relative to the S&P 500. On balance sheet safety, Hippo Holdings Inc. (HIPO) carries a lower debt/equity ratio of 12% versus 34% for Lemonade, Inc. — giving it more financial flexibility in a downturn.

04

Which is growing faster — HIPO or LMND?

By revenue growth (latest reported year), Lemonade, Inc.

(LMND) is pulling ahead at 40. 2% versus 25. 9% for Hippo Holdings Inc. (HIPO). On earnings-per-share growth, the picture is similar: Hippo Holdings Inc. grew EPS 235. 4% year-over-year, compared to 19. 3% for Lemonade, Inc.. Over a 3-year CAGR, HIPO leads at 57. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — HIPO or LMND?

Hippo Holdings Inc.

(HIPO) is the more profitable company, earning 12. 3% net margin versus -22. 4% for Lemonade, Inc. — meaning it keeps 12. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HIPO leads at 13. 5% versus -21. 8% for LMND. At the gross margin level — before operating expenses — HIPO leads at 50. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is HIPO or LMND more undervalued right now?

Analyst consensus price targets imply the most upside for LMND: 37.

1% to $72. 67.

07

Which pays a better dividend — HIPO or LMND?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

08

Is HIPO or LMND better for a retirement portfolio?

For long-horizon retirement investors, Hippo Holdings Inc.

(HIPO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Lemonade, Inc. (LMND) carries a higher beta of 2. 75 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HIPO: -90. 5%, LMND: -23. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between HIPO and LMND?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

HIPO

Quality Mega-Cap Compounder

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 14%
Run This Screen
Stocks Like

LMND

High-Growth Disruptor

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 27%
  • Gross Margin > 28%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform HIPO and LMND on the metrics below

Revenue Growth>
%
(HIPO: 10.2% · LMND: 55.0%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.